Trading Signals: SGEN Stock Price Prediction and Forecast (Fri. May. 30, 2003 - Wed. Dec. 13, 2023)(Seattle Genetics, Inc.)
| SGEN latest price $38.8900 (-1.07%) ($38.3200 - $39.9600) on Tue. Jun. 14, 2016. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.82% (three month average) | RSI | 48 | Latest Price | $38.8900(-1.07%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | SGEN declines -1.7% a day on average for past five trading days. | Market Behavior | Value stocks sell-off for large cap. Value stock sell-off for small cap. | Correlated ETFs | Broad market will support SGEN advance at 0% a week (0% probability) IBB(40%) XBI(35%) XLV(32%) ARKG(29%) IWF(28%) | Factors Impacting SGEN price | SGEN will decline at least -1.41% in a week (0% probabilities). VIXM(-14%) UUP(-7%) TLT(-6%) SHY(-3%) GDXJ(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.41% (StdDev 2.82%) | Hourly BBV | 0 () | Intraday Trend | -1% | | | |
|
Resistance Level | $40.39 | 5 Day Moving Average | $40.4(-3.74%) | 10 Day Moving Average | $41.5(-6.29%) | 20 Day Moving Average | $40.39(-3.71%) | To recent high | -11.2% | To recent low | 22.5% | Market Cap | $6.762b | | | | Seattle Genetics, Inc. is a biotechnology company, which engages in the development and commercialization of antibody-based therapies for the treatment of cancer. Its products include Adcetris and Padcev. The firm is also advancing a pipeline of novel therapies for solid tumors and blood-related cancers. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA. |